Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:25:00 EDT Fri 03 May 2024
Enter Symbol
or Name
USA
CA



News for U:TLTFF from 2023-05-04 to 2024-05-03 - 27 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-02 07:02U:TLTFFNews ReleaseTheralase(R) Expands Clinical Team
2024-04-24 07:03U:TLTFFNews ReleaseTheralase(R) Closes $CAN 750,000 Non-Brokered Private Placement
2024-04-05 07:03U:TLTFFNews ReleaseTheralase(R) Granted Canadian Cancer Vaccine Patent
2024-03-27 07:03U:TLTFFNews ReleaseTheralase(R) Release's 4Q2023 Interim Financial Statements
2024-03-26 07:03U:TLTFFNews ReleaseTheralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association
2024-02-12 07:02U:TLTFFNews ReleaseTheralase(R) Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's Disease
2024-02-08 07:03U:TLTFFNews ReleaseDr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
2024-02-05 16:36U:TLTFFNews ReleaseTheralase(R) Closes $CAN 1.2 Million Non-Brokered Private Placement
2024-01-15 07:02U:TLTFFNews ReleaseTheralase(R) Provides Update on Phase II Bladder Cancer Clinical Study
2023-11-29 18:31U:TLTFFNews ReleaseTheralase Release ¢ € ™s 3Q2023 Interim Financial Statements
2023-11-29 16:37U:TLTFFNews ReleaseTheralase(R) Closes $CAN 1.17 Million Non-Brokered Private Placement
2023-11-17 16:31U:TLTFFNews ReleaseTheralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
2023-10-23 17:56U:TLTFFNews ReleaseTheralase(R) Announces Brokered LIFE Financing
2023-10-23 07:01U:TLTFFNews ReleaseTheralase(R) Optimizes Phase II Bladder Cancer Clinical Study
2023-10-16 07:03U:TLTFFNews ReleaseTheralase(R) Provides Update on Bladder Cancer Clinical Study
2023-10-05 07:01U:TLTFFNews ReleaseTheralase(R) Files US Patent for Enhanced Immunotherapy
2023-09-29 07:02U:TLTFFNews ReleaseTheralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)
2023-09-27 07:02U:TLTFFNews ReleaseTheralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer
2023-09-21 16:36U:TLTFFNews ReleaseTheralase(R) Grants Stock Options
2023-09-07 16:31U:TLTFFNews ReleaseTheralase(R) Closes Private Placement Equity Financing
2023-08-29 16:32U:TLTFFNews ReleaseTheralase Release ¢ € ™s 2Q2023 Interim Financial Statements
2023-06-30 16:35U:TLTFFNews ReleaseTheralase(R) Closes Non-Brokered Private Placement Equity Financing
2023-06-06 07:01U:TLTFFNews ReleaseTheralase(R) Announces Appointment of New Independent Director
2023-05-30 21:30U:TLTFFNews ReleaseTheralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
2023-05-30 19:35U:TLTFFNews ReleaseTheralase(R) Releases 1Q2023 Interim Financial Statements
2023-05-24 18:46U:TLTFFNews ReleaseTheralase(R) Appoints Roger DuMoulin-White as President and Chief Executive Officer
2023-05-10 07:01U:TLTFFNews ReleaseTheralase Provides Update on Phase II Bladder Cancer Study